Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-24

Clinical Trial Update: American Ginseng Treatment for Multiple Sclerosis Related Fatigue [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated American ginseng for fatigue in people with multiple sclerosis; the study completed and results were posted in January 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • American Ginseng (Panax quinquefolius)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2012-01-24